Targeting caspase-8/c-FLIP_L heterodimer in complex II promotes DL-mediated cell death

Area of Science:

• Cellular biology
• Molecular oncology
• Immunology

Background:

• Death receptor (DR) networks regulate apoptosis via DISC and complex II formation.
• FLIPins are small molecules designed to inhibit the caspase-8/c-FLIP_L heterodimer.
• Previous studies showed FLIPins promote apoptosis and caspase-8 activation upon death ligand stimulation.

Purpose of the Study:

• To investigate the efficacy of FLIPin compounds in combination with death ligands (DLs) and SMAC mimetics.
• To analyze the impact of FLIPins on DL-mediated cell death pathways, including apoptosis and necroptosis.
• To explore novel therapeutic strategies targeting DR networks in cancer.

Main Methods:

• Treatment of cancer cell lines (AML, colon, pancreatic) with FLIPins, DLs, and SMAC mimetics.
• Assessment of cell viability loss and cell death induction.
• Analysis of complex II formation and caspase-8 activation.
• Evaluation of apoptosis and necroptosis induction.

Main Results:

• FLIPins significantly enhanced cell death induced by DLs and SMAC mimetics in AML, colon, and pancreatic cancer cells.
• FLIPins potentiated both apoptosis (DL/BV6) and necroptosis (DL/BV6/zVAD-fmk) by increasing complex II formation.
• Targeting the caspase-8/c-FLIP_L heterodimer is crucial for enhancing co-stimulation-induced cell death.

Conclusions:

• FLIPin compounds represent a promising strategy for enhancing cancer cell death when combined with DLs and SMAC mimetics.
• The study highlights the therapeutic potential of targeting the caspase-8/c-FLIP_L heterodimer in DR-mediated cancer therapy.
• These findings open new avenues for developing effective treatments for various cancer types by modulating DR networks.